M. Havrda

发表

SHORT‐TERM EFFECT OF EVIDENCE‐BASED MEDICINE HEART FAILURE THERAPY ON GLOMERULAR FILTRATION RATE IN ELDERLY PATIENTS WITH CHRONIC CARDIORENAL SYNDROME

F. Málek, M. Havrda, Zuzana Fruhaufová, 2009, Journal of the American Geriatrics Society.

Can Renal Parameters Predict the Mortality of Hospitalized COVID-19 Patients?

M. Havrda, A. Sigal, I. Rychlík, 2022, Kidney and Blood Pressure Research.

Extended follow-up of the CYCLOFA-LUNE trial comparing two sequential induction and maintenance treatment regimens for proliferative lupus nephritis based either on cyclophosphamide or on cyclosporine A

Z. Hrnčíř, V. Tesar, J. Slatinská, 2014, Lupus.

THU0280 Extended Follow-Up of the Cyclofa-Lune Trial Comparing Two Sequential Induction and Maintenance Treatment Regimens for Proliferative Lupus Nephritis Based Either on Cyclophosphamide or Cyclosporine a

Z. Hrnčíř, V. Tesar, J. Závada, 2013 .

Cyclosporine A or intravenous cyclophosphamide for lupus nephritis: the Cyclofa-Lune study

Z. Hrnčíř, V. Tesar, J. Závada, 2010, Lupus.

Glomerulonephritides associated with infections.

M. Havrda, 2022, Vnitrni lekarstvi.

Bioptically Proven “Anticoagulation-Related Nephropathy“ Induced by Dual Antiplatelet Therapy

E. Honsova, M. Havrda, I. Rychlík, 2018, Case Reports in Nephrology and Dialysis.

Clinical case: idelalisib-induced immunoglobulin flare

J. Novak, M. Havrda, T. Kozák, 2017, Immunopharmacology and immunotoxicology.

Unveiling the Unexpected: Why Doctors Should Look beyond the Lungs when Predicting COVID-19 Mortality

M. Havrda, M. Rasková, I. Rychlík, 2023, Kidney and Blood Pressure Research.